|
 |
TAKE
The page is no longer available. You may want to read the following pages.
B Bauce, A Rampazzo, C Basso, E Mazzotti... - Heart Rhythm, 2011 - Elsevier Note to users: The section "Articles in Press" contains peer reviewed accepted articles to be published
in this journal. When the final article is assigned to an issue of the journal, the "Article in
Press" version will be removed from this section and will appear in the associated ...
A Boswood, S Smith... - Veterinary Record, 2011 - WE wish to announce the launch of a new study called EPIC (Evaluation of Pimobendan In dogs with Cardiomegaly caused by preclinical mitral valve disease [MVD]). EPIC is a global, randomised, double-blinded, parallel group, placebo-controlled study conducted within ...
V Bhm - Molecular Nutrition & Food Research - Wiley Online Library Cardiovascular diseases (CVDs) are the leading causes of human morbidity and mortality in developed countries. Specific biomarkers in this context are markers of inflammation, lipid status, thrombosis and oxidative stress. One recommendation for CVD prevention is to ...
R Burr... - 2011 - Quality of life after sudden cardiac arrest: Structural equation modeling Quality of life has been conceptualized and measured in diverse ways. The purpose of this study was to test a causal model developed from a theoretical framework of quality of life for chronic illness, ...
A Lamy, PJ Devereaux, D Prabhakaran, S Hu... - American Heart ..., 2012 - Elsevier... The second coprimary outcome is the occurrence of the composite of total mortality, nonfatal
stroke, nonfatal MI, new renal failure, or repeat coronary revascularization (ie, coronary artery
bypass surgery or percutaneous coronary intervention) over 5 years after randomization. ...
[HTML]
|
|
|
